<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0203</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2009-09-30</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001405197</issuerCik>
        <issuerName>Talecris Biotherapeutics Holdings Corp.</issuerName>
        <issuerTradingSymbol>TLCR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000947822</rptOwnerCik>
            <rptOwnerName>FEINBERG STEPHEN</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CERBERUS CAPITAL MANAGEMENT, L.P.</rptOwnerStreet1>
            <rptOwnerStreet2>299 PARK AVENUE - 22ND FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10171</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.01 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>88227868</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By certain limited liability companies and limited partnerships</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes>
        <footnote id="F1">This Form 3 is being filed as a result of the registration, as of 2:00 p.m. (Eastern Standard Time) on September 30, 2009 (the &quot;Effective Time&quot;), of the common stock, par value $0.01 per share (the &quot;Common Stock&quot;), of Talecris Biotherapeutics Holdings Corp., a Delaware corporation (the &quot;Company&quot;), pursuant to the Securities Exchange Act of 1934, as amended, as part of the Company's initial public offering consummated at the Effective Time.</footnote>
        <footnote id="F2">At the Effective Time, Talecris Holdings, LLC, whose managing member is Cerberus-Plasma Holdings LLC, held in the aggregate 88,227,868 shares of Common Stock.  Pursuant to the Amended and Restated Limited Liability Company Agreement of Talecris Holdings, LLC, Cerberus-Plasma Holdings LLC has the authority to vote and dispose of the shares of Common Stock held by Talecris Holdings, LLC.  The managing member of Cerberus-Plasma Holdings LLC is Cerberus Partners, L.P., whose general partner is Cerberus Associates, L.L.C.  Stephen Feinberg is the managing member of Cerberus Associates, L.L.C.  As a result of the foregoing, Mr. Feinberg, through one or more intermediate entities, possesses the sole power to vote and the sole power to direct the disposition of all securities of the Company held by Talecris Holdings, LLC.  Mr. Feinberg's interest in the securities reported herein is limited to the extent of his pecuniary interest in Talecris Holdings, LLC, if any.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Stephen Feinberg</signatureName>
        <signatureDate>2009-09-30</signatureDate>
    </ownerSignature>
</ownershipDocument>
